Intervention Review

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients

  1. Angela C Webster1,*,
  2. Rod RS Taylor2,
  3. Jeremy R Chapman3,
  4. Jonathan C Craig4

Editorial Group: Cochrane Kidney and Transplant Group

Published Online: 19 OCT 2005

Assessed as up-to-date: 21 AUG 2005

DOI: 10.1002/14651858.CD003961.pub2

How to Cite

Webster AC, Taylor RRS, Chapman JR, Craig JC. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD003961. DOI: 10.1002/14651858.CD003961.pub2.

Author Information

  1. 1

    University of Sydney, School of Public Health, Sydney, NSW, Australia

  2. 2

    Peninsula Medical School, PenTAG, Exeter, UK

  3. 3

    Westmead Hospital, Renal Medicine, Westmead, NSW, Australia

  4. 4

    The Children's Hospital at Westmead, Centre for Kidney Research, Westmead, NSW, Australia

*Angela C Webster, School of Public Health, University of Sydney, Edward Ford Building A27, Sydney, NSW, 2006, Australia.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 OCT 2005


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.